Zobrazeno 1 - 10
of 140
pro vyhledávání: '"D. Trueman"'
Autor:
Leslie D. Trueman, Robert Waska
Publikováno v:
Psychodynamic Practice. 28:400-404
Autor:
Hannah Lomax, E Hancock, Raisa Sidhu, D. Viriato, Natalie Bennett, D Trueman, Robert E MacLaren
Publikováno v:
Advances in Therapy
Introduction Voretigene neparvovec (VN) is a gene therapy and the first approved pharmacological treatment for biallelic RPE65-mediated inherited retinal dystrophies (IRD), a rare condition that starts in early life and causes vision to progressively
Publikováno v:
Marine Policy
The Atlantic salmon aquaculture industry has the potential to make a significant contribution to economic development and seafood production globally – particularly in rural and coastal communities. However, the lack of social licence to operate (S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ae3b9e8dbcf8c2ed2310a68e2cfcfd4
https://hdl.handle.net/11250/3015814
https://hdl.handle.net/11250/3015814
Publikováno v:
Value in Health. 25:S445
Autor:
Martin R. Cowie, Fionn Woodcock, Matthew Taylor, E Hancock, D Trueman, R Haroun, Andrew Briggs, C. Deschaseaux, Michael Lacey, Juliet Mumby-Croft, John J.V. McMurray
Publikováno v:
Heart
ObjectiveChronic heart failure with reduced ejection fraction (HF-REF) represents a major public health issue and is associated with considerable morbidity and mortality. We evaluated the cost-effectiveness of sacubitril/valsartan (formerly LCZ696) c
Autor:
Matthew Taylor, Jeanette Kusel, Lindsay Claxton, Timothy Reason, D Trueman, Ruth Pulikottil-Jacob, Robert Hodgson, Rose Wickstead, Adam Jasilek
Publikováno v:
Advances in Therapy
Introduction The estimation of utility values for the economic evaluation of therapies for wet age-related macular degeneration (AMD) is a particular challenge. Previous economic models in wet AMD have been criticized for failing to capture the bilat
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 9, Pp 537-546 (2017)
ClinicoEconomics and Outcomes Research: CEOR
ClinicoEconomics and Outcomes Research: CEOR
Elena Olariu,1 Kevin K Cadwell,1 Elizabeth Hancock,1 David Trueman,1 Helene Chevrou-Severac2 1PHMR Ltd, London, UK; 2Takeda Pharmaceuticals International AG, Zurich, Switzerland Objective: Although Markov cohort models represent one of the most commo
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D Trueman, Juan W. Valle, Srobana Ghosh, E Hancock, Julian Shepelev, Alec Miners, Julie Fricke, N Webb, Julie Winstone
Publikováno v:
ESMO Open, Vol 5, Iss 3 (2020)
ESMO Open
ESMO Open
Background Clinical guidelines recommend that parenteral nutrition (PN) is added to enteral nutrition (EN; supplemental parenteral nutrition (SPN)) in order to meet energy and protein needs in patients with cancer when EN alone is insufficient. Howev
Autor:
Justin D. Trueman, Suzie Currie
Publikováno v:
The FASEB Journal. 32